Manufacturer
Horizon Therapeutics
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 12
- Molecules
- 7
- Therapy areas
- 5
Horizon Therapeutics is a pharmaceutical manufacturer based in United States. MedsAcross lists 12 of its products across 7 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Horizon Therapeutics USA, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Horizon Therapeutics products through licensed channels, with the documents your regulator needs.
Ophthalmology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Procysbi 25 mg delayed-release capsuleOral Cold chain | Cysteamine | US FDA | Available on request |
| Procysbi 300 mg delayed-release granulesOral Cold chain | Cysteamine | US FDA | Available on request |
| Procysbi 75 mg delayed-release granulesOral Cold chain | Cysteamine | US FDA | Available on request |
| Procysbi 75 mg delayed-release capsuleOral Cold chain | Cysteamine | US FDA | Available on request |
Rare diseases and enzyme replacement
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Buphenyl 0.94 g/g oral powderOral | Sodium phenylbutyrate | US FDA | Available on request |
| Buphenyl 500 mg tabletOral | Sodium phenylbutyrate | US FDA | Available on request |
| Ravicti 1.1 g/mL oral liquidOral | Glycerol phenylbutyrate | US FDA | Available on request |
Rheumatology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Krystexxa 8 mg/1 mL injectionIntravenous Cold chain | Pegloticase | US FDA | Available on request |
| Krystexxa 8 mg/50 mL injectionIntravenous Cold chain | Pegloticase | US FDA | Available on request |
Immunology and transplant
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tepezza 500 mg powder for injectionIntravenous Cold chain | Teprotumumab | US FDA | Available on request |
| Uplizna 100 mg/10 mL injectionIntravenous Cold chain | Inebilizumab | US FDA | Available on request |
Multiple sclerosis
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Actimmune 100 mcg/0.5 mL injectionSubcutaneous Cold chain | Interferon gamma-1b | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Horizon Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.